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 Triphala, the formulation for laxative, detoxification, and rejuvenation in Thai traditional medicine and 
Ayurvedic medicine consists of T. chebula var. chebula, T. bellirica, and Phyllanthus emblica fruits. Despite it is a 
popular recipe, the quality of Triphala is not strictly controlled. The powder form of ingredients and the unclearness 
of taxonomical Terminalia species are the important variables that make quality control difficult. In this study, the 
author tried to clarify the relationship of Terminalia spp. and develop the methods for authentication of the Triphala 
ingredients by molecular-biological technique. Nine Terminalia species were collected from Thailand, which five 
of them are utilized as medicines. All specimens were amplified and performed direct sequencing of the ITS region. 
Focused on five medicinal Terminalia species, the aligned ITS nucleotide sequences of T. chebula var. chebula, T. 
chebula var. nana and T. citrina are identical each other, but they have many mismatched nucleotides with T. 
bellirica and T. catappa. Moreover, from the phylogenetic tree reconstruction, Terminalia is divided into two 
groups: an Africa group and Asia group. Furthermore, the author accomplished to find the useful region for DNA 
barcoding. Based on the sequence information, the author developed two methods for authentication. PCR-RFLP 
and ARMS method were selected to compare the authenticate capacity of Triphala and medicinal Terminalia crude 
drugs. As the consequence, the ARMS method was chosen to use for differentiating the ingredients of Triphala, 



























 In this study, nine Terminalia species (Family Combretaceae) collected from Thailand including one of 
the exotic species: T. ivorensis. Five of which namely T. chebula var. chebula, T. chebula var. nana, T. citrina, T. 
bellirica, and T. catappa are utilized as indigenous medicine. Triphala, the famous formulations in Thai traditional 
medicine and Ayurvedic medicine composes of T. chebula var. chebula, T. bellirica and Phyllanthus emblica 
(Family Euphorbiaceae) (Fig. 1). These three crude drugs and nine commercial Triphala formulations were 








 The commercial Triphala and its crude drugs usually found in powder form that it is very tough to 
identify the botanical origin by morphological and chemical methods. DNA technology plays an important role to 
solve these limitations. Eighty-one single nucleotide polymorphisms (SNPs) and nine insertion-deletions (indels) 
were observed, and the nucleotide sequences of this region showed species-specific sequences. Based on these 
differences, the PCR-RFLP method, and the ARMS method were applied to identify medicinal Terminalia species 
and compare the authenticating capacity of Triphala. T. chebula var. chebula, T. bellirica, T. catappa, and P. 
emblica were analyzed for discrimination. Two steps of PCR-RFLP method were performed: (1) the restriction 
enzyme XspI was utilized to recognize T. catappa from the other species (Fig. 2A), and then, (2) the remained 
species were authenticated by Aor13HI enzyme. From 3.0% TAE agarose gel electrophoregram of PCR product, T. 
chebula var. chebula and T. bellirica were able to cleave by the Aor13HI restriction enzyme into three fragments 
and two fragments respectively, while, P. emblica could not to be digested by the same restriction enzyme (Fig. 2B). 
The species-specific primers based on SNPs of the nucleotide sequences of the ITS regions were searched for 
separating the three medicinal Terminalia species and P. emblica. The amplification was conducted with the 
combination of these species-specific primers under resemble concentration and temperature conditions. The 
Fig. 1 Triphala formulation and its ingredients 
A. Terminalia chebula  B. T. bellirica C. Phyllanthus emblica D. Triphala formulation 





























































































































multiplex-ARMS-PCR amplification efficiency produced four apparently amplified PCR products that the four 
pairs of diagnostic primers could be utilized to authenticate all of these four species. Both methods were able to 
authenticate the three medicinal Terminalia species and P. emblica. Nonetheless, the ARMS method had better 
select to conduct for differentiating Terminalia crude drugs including P. emblica crude drugs and the ingredients of 
Triphala because it provides the simplicity and efficiency. This technique achieved to utilize the authenticating by 
using the different length of amplified amplicons: 209 bp for T. bellirica; 266 bp for T. chebula: 497 bp for P. 
emblica (Fig. 3). Consequently, these results clearly exhibited that the ARMS is effective for identification of 






















Fig. 2  PCR-RFLP Analysis Using Restriction Enzymes XspI and Aor13HI 
 3.0% TAE agarose gel electrophoregram of PCR product of P. emblica, T. bellirica, T. catappa, and T. 
chebula var. chebula generated by primers Ter.Af and Ake-26SR, and then digested with restriction enzyme. 
 A. XspI (C^TAG)  
      The ITS1-5.8S-ITS2 fragments of P. emblica, T. bellirica, T. catappa, and T. chebula var. 
chebula were amplified, and digested fragments (left 4 lanes) and non-digested fragments (right 4 lanes) were 
separated by agarose gel electrophoresis, Lane M, 1 kb DNA ladder. 






350 bp  
550 bp  
      The amplified fragments of P. emblica, T. bellirica, and T. chebula var. chebula in the 
ITS1-5.8S-ITS2 region were separated into the cleaved amplicons (left 3 lanes), Lane M, and uncleaved 










Fig. 3  Authentication of P. emblica, T. catappa, T. chebula var. chebula, and  
T. bellirica by ARMS 
 Lanes 1-4 are the same as species-specific primer pairs: 1. PHE.Bf/PHE.Br,                   2. 
TCA.Af/Ter.Br, 3. TCH.Af/Ter.Br, and 4. TBE.Cf/Ter.Br 
 lane M is 1 kb DNA ladder 
 All Terminalia specimens were amplified and performed direct sequencing on the ITS1-5.8S-ITS2 region. 
The aligned sequences obtained from samples with secure identity authentication were used to search the database. 
The query sequences were identified using BLAST database. As a consequence, the BLAST output of Huu Krajong 
(หกูระจง) samples exhibited the highest identities score 99% with T. mantaly. From the result of BLAST output, 
sequencing analysis, and comparison of morphology, Huu Krajong deserved to designate as T. mantaly. The aligned 
ITS1-5.8S-ITS2 nucleotide sequences of five medicinal Terminalia species were correlated each other and analyzed. 
The result revealed that no diversities were observed, even though all specimens were collected from different 
locations. In the ITS region, the nucleotide sequences of T. chebula var. chebula, T. chebula var. nana, and T. 
citrina are identical, but they have many dissimilar nucleotides with T. bellirica and T. catappa. Based on the 
nucleotides obtained in the present study along with those retrieved from DDBJ/EMBL/GenBank DNA database, 
the phylogenetic tree was reconstructed using maximum likelihood method. The tree revealed that Terminalia is 
divided into two groups: an African group with a few taxa from Asia and the Pacific islands and an Asian group.  
 There are four Terminalia medicinal fruits merchandised in local raw drug markets in Thailand: Samo 
thai, Samo thed, Samo deengu, and Samo phiphek. For the safety of patients, the authentication of botanical origin 
is prerequisite before utilization. Recently, DNA barcode was utilized for species identification and classification 
method by using a standardized DNA region. In preliminary research, six candidate markers (rbcL, matK, 
psbA-trnH, ITS, ITS1, and ITS2) were evaluated in nine Terminalia species to find a best marker or combination of 
markers for species level identification. Direct sequencing of Terminalia specimens was compared in each DNA 
barcoding markers. Among all analyzed DNA barcodes, the region that contains the lowest variable sites is rbcL 
(2.59%), whereas, the highest one is ITS2 (27.02%). A total of 116 closely related sequences belonging to nine 
Terminalia nucleotide sequences obtained in this study and 98 sequences retrieved from DDBJ/EMBL/GenBank 
DNA database were analyzed the discrimination performances of the six candidate DNA markers. Three major 
methods of identification: the methods based on sequence comparison ((1) BLAST and (2) genetic method) and (3) 
tree topology. In BLAST1 method, the result revealed that ITS correctly identified 100% at the species and genus 
level. ITS2 ranked first comparable K2P variability consequences in distance method. The data from single markers 
and two-locus combination were conducted phylogenetic tree by using the neighbor-joining (NJ) method. No 
individual markers exhibited clear resolution among nine Terminalia species.  On the other hands, the two-locus 
combination of ITS + psbA-trnH clearly discriminated all the species of Terminalia. As a consequence of three 
methods, in the author opinion, ITS2 is recommended to identifying Terminalia species, which may supplement 
with psbA-trnH. In future, the author will utilize ITS2 to identify four Terminalia medicinal fruits especially Samo 
thai and Samo thed that the botanical origin still ambiguous. 
 The chemical marker constituents in the final product specify in efficacy and safety of medicine. The 
Triphala has been reported that it contains enormous of major tannin-related ingredients namely ellagic acid and 
gallic acid. Moreover, ascorbic acid was found in all of the Triphala ingredients. HPLC has been performed for 
estimating the chemical constituents of Triphala. Thai Triphala and its ingredients including related Terminalia 












 Triphara はタイに流通する重要な製剤で Terminalia chebula, Terminalia bellirica （以
上シクンシ科）, Phyllanthus emblica（トウダイグサ科）の３種類の果実から製される。し
かしその形状は粉末であるため原料の有無や適否を確認することは困難である。 
 発表者は Triphara の分子系統学的手法による原植物の鑑別法及び成分化学的手法によ
る品質管理法を開発することを目的に研究に着手した。まず Terminalia属の２種類の植物
材料に特異的な DNA 配列を見いだすため、タイに分布する主要９種類の Terminalia属植
物を入手し、核（ITS1, ITS2）及び葉緑体 DNA領域（psbA-trnH, matK, rbcL）を解析し
た。この結果を基に簡便法である PCR-RFLP 及び ARMS によるプライマーセットを
ITS1–ITS2 領域に設計し、生薬や製品にも適用可能であることを示した。同時にタンニン
を中心とした成分分析にも着手し、これにより Tripharaの品質管理法が確立する。」」」」」」」」 
 本研究はタイの繁用製剤である Triphara の品質管理に大きく貢献する技術を開発した。
今回の結果に派生して、アジア–アフリカ地域に分布する Terminalia 属の分子系統学的な
近縁関係をも明らかにしている。これらの成果はタイの植物由来製剤の品質安定化に大きく
貢献し、さらに薬学的及び植物学的な重要性を含んでいる。以上、審査委員会は本論文が博
士（学術）に値すると判断した。 
 
 
